Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Revenue projections:

Revenue projections for CAPLIPOINT
Revenue projections for CAPLIPOINT

CAPLIPOINT's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.

Financial Ratios:

currentRatio 0.000000
forwardPE 20.173826
debtToEquity 0.174000
earningsGrowth 0.233000
revenueGrowth 0.112000
grossMargins 0.607490
operatingMargins 0.316470
trailingEps 74.050000
forwardEps 0.000000

CAPLIPOINT's Forward PE is within a good range, showing that the stock price compares well to its earnings. This suggests it isn't overpriced and leaves room for growth, making the stock appealing to investors looking for value and growth opportunities.
Caplin Point Laboratories Limited's positive earnings and revenue growth signal the company's business is on track for further expansion. These strong financial trends suggest that Caplin Point Laboratories Limited will continue to grow its operations, driven by increasing profits and revenue.
With positive gross and operating margins, CAPLIPOINT's profitability is evident. These metrics suggest the company is efficiently managing its expenses while maintaining strong revenue, highlighting a solid financial foundation.

Price projections:

Price projections for CAPLIPOINT
Price projections for CAPLIPOINT

Over time, price projections for Caplin Point Laboratories Limited have been gradually revised upward, reflecting increasing optimism about the company's future performance. This trend suggests analysts are growing more confident in Caplin Point Laboratories Limited's ability to deliver strong results and achieve higher market value.

Recommendation changes over time:

Recommendations trend for CAPLIPOINT
Recommendations trend for CAPLIPOINT


Analysts are favoring CAPLIPOINT with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider CAPLIPOINT as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.